BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 5922599)

  • 1. Assessment of body stores of vitamin B12 during maintenance therapy of pernicious anaemia with depot cyanocobalamin preparation (Betolvex).
    Bastrup-Madsen P
    Scand J Haematol; 1966; 3(3):165-74. PubMed ID: 5922599
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of vitamin B12 deficiency. Evaluation of therapy with cyanocobalamin, hydroxocabalamin, and depot cobalamin Betolvex.
    Bastrup-Madsen P
    Scand J Gastroenterol Suppl; 1974; 29():89-95. PubMed ID: 4530460
    [No Abstract]   [Full Text] [Related]  

  • 3. Long term therapy of pernicious anaemia with the depot cobalamin preparation betolvex.
    Bastrup-Madsen P; Helleberg-Rasmussen I; Nørregaard S; Halver B; Hansen T
    Scand J Haematol; 1983 Jul; 31(1):57-62. PubMed ID: 6867609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin B-12.
    Br Med J; 1968 Oct; 4(5624):167-8. PubMed ID: 5681057
    [No Abstract]   [Full Text] [Related]  

  • 5. Vitamin B12 body stores during oral and parenteral treatment of pernicious anaemia.
    Berlin R; Berlin H; Brante G; Pilbrant A
    Acta Med Scand; 1978; 204(1-2):81-4. PubMed ID: 685735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison between the durations of the effects of the vitamin B12 preparations Betolvex and Vibeden].
    Bastrup-Madsen P
    Ugeskr Laeger; 1973 Sep; 135(38):2037-41. PubMed ID: 4774011
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum-vitamin B12 during maintenance therapy in pernicious anemia with a depot preparation of vitamin B12.
    Bastrup-Madsen P; Schwartz M; Norregaard S; Hansen T; Meulengracht E
    Lancet; 1966 Apr; 1(7440):739-41. PubMed ID: 4159722
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of liver extract and vitamin B12 (cyanocobalamin) in maintenance treatment of pernicious anaemia.
    BLACKBURN EK; BURKE J; ROSEMAN C; WAYNE EJ
    Br Med J; 1952 Aug; 2(4778):245-8. PubMed ID: 14935383
    [No Abstract]   [Full Text] [Related]  

  • 9. Oral treatment of pernicious anemia with high doses of vitamin B12 without intrinsic factor.
    Berlin H; Berlin R; Brante G
    Acta Med Scand; 1968 Oct; 184(4):247-58. PubMed ID: 5751528
    [No Abstract]   [Full Text] [Related]  

  • 10. [Restorative treatment of pernicious anemia with the B 12-preparation Betolvex with depot action].
    MEULENGRACHT E
    Ugeskr Laeger; 1962 Nov; 124():1693-5. PubMed ID: 13935228
    [No Abstract]   [Full Text] [Related]  

  • 11. [Serum vitamin B level in long-term treatment of pernicious anemia with depot vitamin B 12 (Betolvex)].
    Bastrup-Madsen P; Norregaard S; Schwartz M; Hansen T; Meulengracht E
    Ugeskr Laeger; 1966 Mar; 128(9):261-4. PubMed ID: 5915744
    [No Abstract]   [Full Text] [Related]  

  • 12. [Oral treatment of pernicious anaemia].
    Stefanović S; Konecni J; Banićević B; Veljović R
    Srp Arh Celok Lek; 1966 Jun; 94(6):535-40. PubMed ID: 5962818
    [No Abstract]   [Full Text] [Related]  

  • 13. Crude or refined intrinsic factor in preparations for the oral treatment of pernicious anaemia.
    Berlin H; Berlin R; Brante G
    Scand J Haematol; 1966; 3(3):236-44. PubMed ID: 5950927
    [No Abstract]   [Full Text] [Related]  

  • 14. Maintenance therapy of pernicious anaemia. Comparison of cyanocobalamin, hydroxocobalamin and a cyanocobalamin-zinc-tannate complex.
    Killander A; Werner I
    Acta Haematol; 1968; 40(6):305-14. PubMed ID: 4978697
    [No Abstract]   [Full Text] [Related]  

  • 15. [Oral therapy of pernicious anemia with large doses of B 12 without intrinsic factor].
    Berlin R; Brante G
    Nord Med; 1971; 86(49):1490-1. PubMed ID: 5137031
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antibodies against intrinsic factor in oral treatment of pernicious anemia with highly purified hog intrinsic factor-vitamin B 12 complex].
    Neumann E; Honetz N
    Blut; 1972 Jan; 24(1):6-11. PubMed ID: 5062025
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of serum vitamin B 12 binding on intrinsic factor antibody detection in pernicious anaemia.
    Ghazi HA
    Acta Haematol; 1972; 47(5):264-8. PubMed ID: 4625456
    [No Abstract]   [Full Text] [Related]  

  • 18. [Letter: Betolvex and Vibeden].
    Kristensen HP
    Ugeskr Laeger; 1973 Oct; 135(43):2331. PubMed ID: 4775659
    [No Abstract]   [Full Text] [Related]  

  • 19. [Dosage of liver extracts and concentrated vitamin B12 preparations in pernicious anemia].
    VILLINGER-KWERCH H
    Med Klin; 1952 Aug; 47(35):1147-8. PubMed ID: 13001841
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical evaluation of simultaneously administered 58Co labelled vitamin B12 and 57Co labelled vitamin B12 bound to intrinsic factor in patients with pernicious anaemia.
    Celada A; Herreros V; Donath A
    Blut; 1981 Feb; 42(2):87-93. PubMed ID: 7470641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.